Delivery Order SPE2DB22D1103-SPE2DB24FTEK0
Award Date 1/26/24
Potential Completion Date 1/29/24
Potential Value $2.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRULICITY 0.75 mg/0.5 ml pens. The $7,965.65 contract has an ultimate completion date of April 2, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a potential value of $1,464.52 and a completion date of January 26, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the medication TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract, valued at $2,283.17, has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $13,953.86, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceuticals. The delivery order has a potential value of $5,805.60 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designations. Amerisourcebergen Drug Corp also holds an...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $2,902.80 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. The company also holds an indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order, valued at $3,542.40, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $1,863.36 contract has a completion date of March 8, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 2025 to deliver a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,851.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $3,940.92, runs through April 19, 2024 and was issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This IDC...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTEK0Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a potential value of $2,760.96 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designations were used for this award.
Generated 4/26/24, 11:42 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/26/24 |